跳至主要内容
临床试验/NCT02292797
NCT02292797已完成不适用

Assessment of the Prevalence of Rosacea in the General Population

Galderma R&D0 个研究点目标入组 6,000 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
6,000
主要终点
percentage of subjects with rosacea diagnosis confirmed

研究概览

简要总结

Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.

详细描述

Primary objective:

Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The following subjects will be included in the study:
  • Subjects aged 18 to 65 years old from the general population
  • Subjects who are willing to complete the questionnaires
  • Inclusion Criteria:
  • The following subjects will be included in Part II of the study:
  • Subjects who screened positive for rosacea during the first part of the study and selected by random method
  • Subjects who gave their informed consent to participate in Part II of the study

排除标准

  • 未提供

结局指标

主要结局

percentage of subjects with rosacea diagnosis confirmed

时间窗: general population will be surveyed over an expected average duration of 6 months

estimation of the percentage of rosacea patients in the general population

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

相似试验